These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25069786)

  • 41. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
    Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
    J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.
    Cozzi NV; Daley PF
    Drug Test Anal; 2020 Oct; 12(10):1483-1493. PubMed ID: 32608093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
    Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
    Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
    Strassman RJ; Qualls CR; Berg LM
    Biol Psychiatry; 1996 May; 39(9):784-95. PubMed ID: 8731519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations.
    Eckernäs E; Timmermann C; Carhart-Harris R; Röshammar D; Ashton M
    Clin Transl Sci; 2022 Dec; 15(12):2928-2937. PubMed ID: 36088656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
    Jacob MS; Presti DE
    Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca.
    Yritia M; Riba J; Ortuño J; Ramirez A; Castillo A; Alfaro Y; de la Torre R; Barbanoj MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):271-81. PubMed ID: 12361741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
    Callaway JC; Raymon LP; Hearn WL; McKenna DJ; Grob CS; Brito GS; Mash DC
    J Anal Toxicol; 1996 Oct; 20(6):492-7. PubMed ID: 8889686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).
    Brown T; Shao W; Ayub S; Chong D; Cornelius C
    J Psychoactive Drugs; 2017; 49(4):294-296. PubMed ID: 28686543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
    Frecska E; Szabo A; Winkelman MJ; Luna LE; McKenna DJ
    J Neural Transm (Vienna); 2013 Sep; 120(9):1295-303. PubMed ID: 23619992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
    Uthaug MV; Lancelotta R; van Oorsouw K; Kuypers KPC; Mason N; Rak J; Šuláková A; Jurok R; Maryška M; Kuchař M; Páleníček T; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2019 Sep; 236(9):2653-2666. PubMed ID: 30982127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of N,N-dimethyltryptamine in Humans.
    Good M; Joel Z; Benway T; Routledge C; Timmermann C; Erritzoe D; Weaver R; Allen G; Hughes C; Topping H; Bowman A; James E
    Eur J Drug Metab Pharmacokinet; 2023 May; 48(3):311-327. PubMed ID: 37086340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Montero M; Callaway JC; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Feb; 154(1):85-95. PubMed ID: 11292011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.
    Davis AK; Barsuglia JP; Lancelotta R; Grant RM; Renn E
    J Psychopharmacol; 2018 Jul; 32(7):779-792. PubMed ID: 29708042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.
    Pallavicini C; Cavanna F; Zamberlan F; de la Fuente LA; Ilksoy Y; Perl YS; Arias M; Romero C; Carhart-Harris R; Timmermann C; Tagliazucchi E
    J Psychopharmacol; 2021 Apr; 35(4):406-420. PubMed ID: 33567945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative analysis of substituted N,N-dimethyl-tryptamines in the presence of natural type XII alkaloids.
    Ivanova B; Spiteller M
    Nat Prod Commun; 2012 Oct; 7(10):1273-6. PubMed ID: 23156988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.
    Vogt SB; Ley L; Erne L; Straumann I; Becker AM; Klaiber A; Holze F; Vandersmissen A; Mueller L; Duthaler U; Rudin D; Luethi D; Varghese N; Eckert A; Liechti ME
    Transl Psychiatry; 2023 May; 13(1):172. PubMed ID: 37221177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.